You are here:   HomeNews ReleasesElse Nutrition Receives Favorable Regulatory Assessment Ahead of U.S. Market Launch
Print

VANCOUVER, Dec. 16, 2019 /CNW/ - ELSE NUTRITION HOLDINGS INC(TSX-V: BABY, OTCQB: BABYF) ("Else" or the "Company"), a developer of plant-based alternatives to dairy-based baby nutrition, announces that it has received a favorable regulatory assessment of its toddler formula ingredients from EAS Consulting Group, LLC, which conducted a preliminary review of the Else formula in view of the FDA (Food and Drug Administration) requirements. 

With vast, global expertise in regulatory approvals, and specialty in FDA requirements, EAS has unique experience and capability pertaining to the introduction of food, drinks and new infant formulas.

"The EAS Infant Formula Team has confirmed that Else toddler formula intended to be marketed in the U.S. meets the regulatory requirements for general food as required for a toddler formula," stated Dr. Fabiana Bar-Yoseph, Else's Director of Clinical Development, Regulatory and Scientific Affairs. She added, "This regulatory validation marks a significant step as we look to bring a nutritious, plant-based toddler formula to the U.S. market."

Else Nutrition's 100% plant-based toddler formula is set to launch in the U.S. market in the second quarter of 2020.